Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Language
Year range
1.
Rev. Soc. Bras. Med. Trop ; 51(1): 66-70, Jan.-Feb. 2018. graf
Article in English | LILACS | ID: biblio-1041442

ABSTRACT

Abstract INTRODUCTION: Pseudo-infectious yellow fever viral particles (YFV-PIVs) have been used to study vaccines and viral packaging. Here, we report the development of a packaging cell line, which expresses the YFV prM/E proteins. METHODS: HEK293 cells were transfected with YFV prM/E and C (84 nt) genes to generate HEK293-YFV-PrM/E-opt. The cells were evaluated for their ability to express the heterologous proteins and to package the replicon repYFV-17D-LucIRES, generating YFV-PIVs. RESULTS: The expression of prM/E proteins was confirmed, and the cell line trans-packaged the replicon for recovery of a reporter for the YFV-PIVs. CONCLUSIONS: HEK293-YFV-prM/E-opt trans-packaging capacity demonstrates its possible biotechnology application.


Subject(s)
Humans , Virus Replication/immunology , Yellow fever virus/immunology , Virus Assembly/immunology , Vaccines, Virus-Like Particle/immunology , Virus Replication/genetics , Yellow fever virus/genetics , Virus Assembly/genetics , Fluorescent Antibody Technique, Indirect , Green Fluorescent Proteins , HEK293 Cells , Vaccines, Virus-Like Particle/genetics , Flow Cytometry
2.
Mem. Inst. Oswaldo Cruz ; 110(5): 677-683, Aug. 2015. tab, ilus
Article in English | LILACS | ID: lil-755902

ABSTRACT

Full-length dengue virus (DENV) cDNA clones are an invaluable tool for many studies, including those on the development of attenuated or chimeric vaccines and on host-virus interactions. Furthermore, the importance of low passage DENV infectious clones should be highlighted, as these may harbour critical and unique strain-specific viral components from field-circulating isolates. The successful construction of a functional Brazilian low passage DENV serotype 2 full-length clone through homologous recombination reported here supports the use of a strategy that has been shown to be highly useful by our group for the development of flavivirus infectious clones and replicons.

.


Subject(s)
DNA, Complementary/genetics , Dengue Virus/genetics , RNA, Viral/genetics , Brazil , Cloning, Molecular , Molecular Sequence Data , Sequence Analysis, DNA , Virus Replication
3.
Mem. Inst. Oswaldo Cruz ; 108(8): 983-991, 6/dez. 2013.
Article in English | LILACS | ID: lil-697152

ABSTRACT

Dengue virulence and fitness are important factors that determine disease outcome. However, dengue virus (DENV) molecular biology and pathogenesis are not completely elucidated. New insights on those mechanisms have been facilitated by the development of reverse genetic systems in the past decades. Unfortunately, instability of flavivirus genomes cloned in Escherichia coli has been a major problem in these systems. Here, we describe the development of a complete reverse genetics system, based on the construction of an infectious clone and replicon for a low passage DENV-3 genotype III of a clinical isolate. Both constructs were assembled into a newly designed yeast- E. coli shuttle vector by homologous recombination technique and propagated in yeast to prevent any possible genome instability in E. coli . RNA transcripts derived from the infectious clone are infectious upon transfection into BHK-21 cells even after repeated passages of the plasmid in yeast. Transcript-derived DENV-3 exhibited growth kinetics, focus formation size comparable to original DENV-3 in mosquito C6/36 cell culture. In vitro characterisation of DENV-3 replicon confirmed its identity and ability to replicate transiently in BHK-21 cells. The reverse genetics system reported here is a valuable tool that will facilitate further molecular studies in DENV replication, virus attenuation and pathogenesis.


Subject(s)
Dengue Virus/genetics , Reverse Genetics , RNA, Viral/genetics , Virus Replication/genetics , Escherichia coli/genetics , Genetic Vectors/genetics , Plasmids
SELECTION OF CITATIONS
SEARCH DETAIL